Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
304 participants
INTERVENTIONAL
2013-11-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries
NCT01563289
Topical Ibuprofen for Delayed Onset Mulscle Soreness
NCT01794923
Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries
NCT01562717
A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.
NCT00261560
Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain
NCT05013567
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Topical IBU twice daily
Topical IBU twice daily
Topical gel administered as 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Placebo twice daily
Placebo twice daily
Topical gel administered as a 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Topical IBU three times daily
Topical IBU three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Placebo three times daily
Placebo three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical IBU twice daily
Topical gel administered as 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Placebo twice daily
Topical gel administered as a 4 inch strip twice daily for 7 days, and as needed for an additional 3 days
Topical IBU three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Placebo three times daily
Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medically cleared to participate
Exclusion Criteria
* Requires bed rest, surgery, or over-the-counter or prescription analgesics
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helen Keller Hospital
Sheffield, Alabama, United States
Visions Clinical Research - Tucson
Tucson, Arizona, United States
Orange County Research Institute
Anaheim, California, United States
eStudy Site
San Diego, California, United States
San Diego Sports Medicine and Family Health Center
San Diego, California, United States
Sunrise Research Institute, Inc.
Miami, Florida, United States
L&L Research Choices
Miami, Florida, United States
Doctors Research Network
South Miami, Florida, United States
Elite Clinical Trials LLLP
Blackfoot, Idaho, United States
MedPharmics, LLC
Metairie, Louisiana, United States
Quality Clinical Research, Inc.
Omaha, Nebraska, United States
Heartland Clinical Research, Inc.
Omaha, Nebraska, United States
PMG Research of Salisbury
Salisbury, North Carolina, United States
Lillestol Research, LLC
Fargo, North Dakota, United States
Clinical Trial Network
Houston, Texas, United States
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Clinical Trials of Texas
San Antonio, Texas, United States
Sports Medicine Associates of San Antonio
San Antonio, Texas, United States
Danville Orthopedic Clinic
Danville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B3491009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.